Reuters logo
BRIEF-Capricor Therapeutics reports Q3 loss per share $0.12
November 8, 2017 / 9:06 PM / 16 days ago

BRIEF-Capricor Therapeutics reports Q3 loss per share $0.12

Nov 8 (Reuters) - Capricor Therapeutics Inc:

* Capricor Therapeutics reports third quarter 2017 financial results and provides update on duchenne muscular dystrophy development program

* Q3 loss per share $0.12 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below